Search

Middle East respiratory syndrome (MERS) is a lethal respiratory disease with its first case reported back in 2012 (Jeddah, Saudi Arabia). It is a novel, single-stranded, positive-sense RNA beta coronavirus (MERS-CoV) that was isolated from a patient who died from a severe respiratory illness. Later, it was found that this patient was infected with MERS. MERS is endemic to countries in the Middle East regions, such as Saudi Arabia, Jordan, Qatar, Oman, Kuwait and the United Arab Emirates. It has been reported that the MERS virus originated from bats and dromedary camels, the natural hosts of MERS-CoV. The transmission of the virus to humans has been thought to be either direct or indirect. Few camel-to-human transmissions were reported earlier. However, the mode of transmission of how the virus affects humans remains unanswered. Moreover, outbreaks in either family-based or hospital-based settings were observed with high mortality rates, especially in individuals who did not receive proper management or those with underlying comorbidities, such as diabetes and renal failure. Since then, there have been numerous reports hypothesising complications in fatal cases of MERS. Over the years, various diagnostic methods, treatment strategies and preventive measures have been strategised in containing the MERS infection. Evidence from multiple sources implicated that no treatment options and vaccines have been developed in specific, for the direct management of MERS-CoV infection. Nevertheless, there are supportive measures outlined in response to symptom-related management. Health authorities should stress more on infection and prevention control measures, to ensure that MERS remains as a low-level threat to public health.

An outbreak of coronavirus pneumonia was firstly documented in Wuhan, Hubei Province, China (December 2019), with an indication of human-to-human transmission. The causative agent identified for coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). America, Italy, India, and Africa became new venues of COVID infection; the overall data of patients and death is increasing day by day. Generally inplace of most of the infected people develop respiratory symptoms (throat pain, cough, etc.), fever, and chest opacity on CT scan and X-ray. A few numbers of suspected persons are found asymptomatic; they may serve as carriers for infection. As a point of care, the patient diagnosis is compulsory, and only the diagnosis can provide a real-time condition of patients and can be helpful in arresting the spreading of the infection. In the present chapter, we focused on illustrating various diagnostic techniques that have been employed by the world for the detection of the coronavirus. The diagnostic techniques are categorized into molecular and serologic assay techniques. The nucleic acid is detected in molecular assay, whereas the serologic assay uses antigen-antibody reaction.

Pulmonary hypertension is a chronic and advanced disease associated with increased resistance to the pulmonary vasculature, which causes changes in the morphology of the pulmonary arteries and is a major reason for death worldwide. It is associated more in women than in men. It remains asymptomatic until the harmful effects of hypertension such as stroke, myocardial infarction, etc. are observed. Synthetic drugs are used to overcome this disease, but they produce serious side effects, so alternative medicines from medicinal plants need to be developed. Traditionally, medicinal plants have been used since ancient time and are shown to be effective. Examples of plants include Moringa Oleifera Lam, Allium sativum L., Terminalia Arjuna, Withania Somnifera, and many more. They act by decreasing SOD, increasing nitric oxide levels, and also lowering the BCL2/BAX ratio. This chapter focuses on the recent discovery of medicinal plants and its phytoconstituents used in the treatment of pulmonary hypertension and the pathways involved.

In pharmaceutical industry there are some possibilities of contamination and cross-contamination because of improper cleaning of equipment, apparatus, processing area or the starting material, this can lead to severe hazards, therefore in pharmaceutical industry we can’t afford any contamination as well as cross contamination. This can be minimized by proper cleaning of equipment, apparatus as well as the processing area. TheIndustry wants to achieve these main goals with the help of GMP. This review focused on the different types of cleaning process adapted by pharmaceutical industry, how the process of cleaning validation is done. In the cleaning validation different critical parameter, factor, material and critical process are monitored and validated so that the cleaning consistency can be achieved and documented accordingly. Keywords: Cleaning validation, contamination, clean in place, clean out of place, swab sampling, worst case

Tinospora cordifolia is a popular medicinal plant which is used in several traditional medicines to cure various diseases. The common names are Amrita and Guduchi and belong to the family of Menispermaceae. It is considered an essential herbal plant of Indian system of medicine (ISM) and has been used in the treatment of fever, urinary problem, dysentery, skin diseases leprosy, diabetes, and many more diseases. The plant reported containing chemical compound including Alkaloids, Terpenoids, Lignans, Steroids and others that establish the phytochemistry and pharmacological activity of Tinospora cordifolia. The present review highlights the pharmacological importance viz antioxidant activity, antimicrobial activity, antibacterial activity, antifungal activity, anti-diabetic activity, antistress activity, hypolipidaemic effect, hepatic disorder, anticancer anti HIV potential, antiosteoporotic effects, antitoxic effects, wound healing, anticomplementary activity, and immunomodulating activity, systemic infection and Parkinson ̓s disease.